Insiders / Duncan Barbara Gayle / Activity
Activity — Duncan Barbara Gayle
7 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | Exercise | AVIR Atea Pharmaceuticals, Inc. Common Stock | $0 | +30K +47.17% | 92,350 0.12% of shares | low |
| May 5, 2026 | Grant | HALO Halozyme Therapeutics Inc Common Stock | $0 | +4K +19.06% | 23,715 0.02% of shares | low |
| Jun 18, 2026 | Grant | AVIR Atea Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | +38K | 37,700 0.05% of shares | low |
| Jun 18, 2026 | Grant | AVIR Atea Pharmaceuticals, Inc. Restricted Stock Units | — | +27K | 26,700 0.03% of shares | low |
| Jun 18, 2026 | Exercise | AVIR Atea Pharmaceuticals, Inc. Restricted Stock Units | — | -30K -100.00% | 0 0.00% of shares | low |
| May 5, 2026 | Grant | HALO Halozyme Therapeutics Inc Option to Purchase Common Stock | — | +6K | 6,040 <0.01% of shares | low |
| Feb 26, 2026 | Grant | OVID Ovid Therapeutics Inc. Employee Stock Option (Right to Buy) | — | +65K | 65,000 0.03% of shares | low |